News Consumer group calls for antidiabetes drug to be withdrawn BMJ 2012; 344 doi: https://doi.org/10.1136/bmj.e3259 (Published 08 May 2012) Cite this as: BMJ 2012;344:e3259 Article Related content Metrics Responses Peer review Related articles Correction Consumer group calls for antidiabetes drug to be withdrawn Published: 11 May 2012; BMJ 344 doi:10.1136/bmj.e3370 Letter Novo Nordisk’s reply to call for withdrawal of liraglutide Published: 01 June 2012; BMJ 344 doi:10.1136/bmj.e3706 Research Incretin treatment and risk of pancreatitis in patients with type 2 diabetes mellitus: systematic review and meta-analysis of randomised and non-randomised studies Published: 15 April 2014; BMJ 348 doi:10.1136/bmj.g2366 See more GSK settles most US lawsuits over Zantac for $2.2bn BMJ October 11, 2024, 387 q2249; DOI: https://doi.org/10.1136/bmj.q2249 What do we know about covid-19’s effects on the gut? BMJ May 01, 2024, 385 q842; DOI: https://doi.org/10.1136/bmj.q842 Cholera: Malawi is in grip of its deadliest outbreak BMJ February 09, 2023, 380 p328; DOI: https://doi.org/10.1136/bmj.p328 Emergency care is in “dire” situation after loss of NHS beds, says royal college BMJ May 31, 2022, 377 o1376; DOI: https://doi.org/10.1136/bmj.o1376 GP efforts to cut antibiotic use failed to curb spread of drug resistant E coli, evaluation finds BMJ August 05, 2021, 374 n1953; DOI: https://doi.org/10.1136/bmj.n1953 Cited by... Incretin treatment and risk of pancreatitis in patients with type 2 diabetes mellitus: systematic review and meta-analysis of randomised and non-randomised studiesAbstract Fulltext PDF Novo Nordisk's reply to call for withdrawal of liraglutideAbstract Fulltext PDF
